Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

NSE:INDRAMEDCO Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	1,921	1,836	1,610	1,240	861.5	586.2
Depreciation & Amortization	461.1	431.3	438.7	394.6	378.4	332.7
Other Amortization	5	5	4.6	6.2	14.3	16.7
Loss (Gain) From Sale of Assets	3.5	5.3	5.2	11.7	8.7	57.7
Loss (Gain) From Sale of Investments	-33.8	-11.4	-	-	-	-
Other Operating Activities	-187.3	-292.1	-252.9	-205.2	115.2	-15.8
Change in Accounts Receivable	-377.6	-319.1	-193.6	138.7	-234.9	259.5
Change in Inventory	-3.6	-8.7	5.4	9.2	15.4	-12.5
Change in Accounts Payable	44.2	27.9	-49.8	406.7	286.1	-281.5
Operating Cash Flow	1,833	1,674	1,568	2,002	1,445	943
Operating Cash Flow Growth	6.71%	6.82%	-21.68%	38.54%	53.20%	251.73%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-795	-596.5	-363.3	-693.9	-445.8	-294.8
Investment in Securities	-1,003	11.4	-	-	-	-
Other Investing Activities	475.6	-1,191	-746.6	-890.4	-633.3	-446.3
Investing Cash Flow	-1,322	-1,776	-1,110	-1,584	-1,079	-741.1

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Long-Term Debt Repaid	-	-24.3	-21.3	-37.9	-28.3	-25.1
Lease Payments	-32.4	-24.3	-21.3	-37.9	-28.3	-25.1
Total Debt Repaid	-32.4	-24.3	-21.3	-37.9	-28.3	-25.1
Net Debt Issued (Repaid)	-32.4	-24.3	-21.3	-37.9	-28.3	-25.1
Common Dividends Paid	-408	-410.3	-407.3	-275.4	-228.4	-2.6
Other Financing Activities	-31	-29.2	-30.2	-10.5	-3.7	-6
Financing Cash Flow	-471.4	-463.8	-458.8	-323.8	-260.4	-33.7

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	39.3	-565.5	-1.2	93.4	105.2	168.2

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	1,038	1,078	1,204	1,308	998.9	648.2
Free Cash Flow Growth	-27.42%	-10.49%	-7.91%	30.90%	54.10%	1008.03%
Free Cash Flow Margin	6.67%	7.27%	8.88%	10.51%	9.09%	7.30%
Free Cash Flow Per Share	11.32	11.76	13.14	14.26	10.90	7.07
Levered Free Cash Flow	752.98	673.36	1,177	1,139	956.2	606.55
Unlevered Free Cash Flow	772.79	691.68	1,196	1,146	959.08	610.36
Free Cash Flow After Leases	1,005	1,054	1,183	1,270	970.6	623.1

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	31.2	29.3	30.3	10.6	4.6	6.1
Cash Income Tax Paid	1,296	669.2	609.8	468.3	98.5	195.1
Change in Working Capital	-337	-299.9	-238	554.6	66.6	-34.5

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error